Myriad Genetics (MYGN) Net Margin Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Net Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -25.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 454.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 132.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 558.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -113.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 112.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -433.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 209.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 25.00 |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -1,696.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,696.00 |
| Dec 31, 2025 | 1,641.00 |
| Sep 30, 2025 | -296.00 |
| Jun 30, 2025 | -13,774.00 |
| Mar 31, 2025 | 1,281.00 |
| Dec 31, 2024 | -431.00 |
| Sep 30, 2024 | 2,158.00 |
| Jun 30, 2024 | 4,592.00 |
| Mar 31, 2024 | 1,733.00 |
| Dec 31, 2023 | 792.00 |
| Sep 30, 2023 | -950.00 |
| Jun 30, 2023 | -5,541.00 |
| Mar 31, 2023 | -1,776.00 |
| Dec 31, 2022 | -1,906.00 |
| Sep 30, 2022 | -3,715.00 |
| Jun 30, 2022 | -538.00 |
| Mar 31, 2022 | 1,039.00 |
| Dec 31, 2021 | 1,299.00 |
| Sep 30, 2021 | 6,090.00 |
| Jun 30, 2021 | 6,389.00 |